Clinical Trials Directory

Trials / Completed

CompletedNCT03054480

Fractional Micro-Needle Radiofrequency and I Botulinum Toxin A for Primary Axillary Hyperhidrosis

A Comparative Study for Efficacy and Safety Between Fractional Micro-Needle Radiofrequency (FRM) and Intradermal Botulinum Toxin A for the Treatment of Primary Axillary Hyperhidrosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Mae Fah Luang University Hospital · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Because of the limiting data about an efficacy and safety of fractional radiofrequency for the treatment of hyperhidrosis, this study aim to compare clinical efficacy by Hyperhidrosis Disease Severity Score (HDSS) between Fractional Microneedle Radiofrequency device and intradermal Botulinum toxin type A injection for the treatment of primary axillary hyperhidrosis. The secondary objectives to determine the improvement change of iodine starch test, total amount of sweat production by trans-epidermal water loss (TEWL), patient's satisfaction and their quality of life by Dermatology Life Quality Index and side effect between the groups.

Conditions

Interventions

TypeNameDescription
DEVICEFractional Micro-Needle Radiofrequency
DRUGBotulinum toxin type A

Timeline

Start date
2016-08-01
Primary completion
2016-12-31
Completion
2017-01-31
First posted
2017-02-15
Last updated
2017-02-16

Source: ClinicalTrials.gov record NCT03054480. Inclusion in this directory is not an endorsement.